Abstract Hepatic lipase (HL) and endothelial lipase (EL) share overlapping and complementary roles in lipoprotein metabolism. The deletion of HL and EL alleles in mice raises plasma total cholesterol and phospholipid concentrations. However, the influence of HL and EL in vivo on individual molecular species from each class of lipid is not known. We hypothesized that the loss of HL, EL, or both in vivo may affect select molecular species from each class of lipids. To test this hypothesis, we performed lipidomic analyses on plasma and livers from fasted female wildtype, HL-knockout, EL-knockout, and HL/EL-double knockout mice. Overall, the loss of HL, EL, or both resulted in minimal changes to hepatic lipids; however, select species of CE were surprisingly reduced in the livers of mice only lacking EL. The loss of HL, EL, or both reduced the plasma concentrations for select molecular species of triacylglycerol, diacylglycerol, and free fatty acid. On the other hand, the loss of HL, EL, or both raised the plasma concentrations for select molecular species of phosphatidylcholine, cholesteryl ester, diacylglycerol, sphingomyelin, ceramide, plasmanylcholine, and plasmenylcholine. The increased plasma concentration of select ether phospholipids was evident in the absence of EL, thus suggesting that EL might exhibit a phospholipase A 2 activity. Using recombinant EL, we showed that it could hydrolyse the artificial phospholipase A 2 substrate 4-nitro-3-(octanoyloxy)benzoic acid. In summary, our study shows for the first time the influence of HL and EL on individual molecular species of several classes of lipids in vivo using lipidomic methods.
Introduction
Hepatic lipase (HL) and endothelial lipase (EL) are members of an extracellular lipase family that hydrolyse triacylglycerols (TAG) and phospholipids (PL) within circulating lipoproteins [1] . The expression of HL and EL are mainly distinct from each other, whereby HL is expressed primarily by hepatocytes [2, 3] , and EL is expressed in vascular endothelial cells [4, 5] . However, both HL and EL are commonly expressed in macrophages [6, 7] . The expressed lipases are exposed to the bloodstream, where they can hydrolyse TAG and PL from all classes of lipoproteins [1] ; however, EL preferentially hydrolyses PL from high-density lipoproteins (HDL) [8] . In addition to their catalytic functions, HL and EL also have a non-catalytic ''bridging'' function: HL and EL associated with cell surfaces can capture lipoproteins independent of hydrolytic activity [9] [10] [11] [12] , thus bringing lipoproteins in close proximity to various cell surface molecules associated with lipoprotein metabolism.
Previous studies using HL-knockout (ko), EL-ko, and HL/EL-double ko (dko) mice have shown that HL and EL exhibit complementary and redundant roles in lipoprotein metabolism. The genetic ablation of alleles for both HL and EL lead to increased levels of plasma total cholesterol, HDL cholesterol (HDL-C), non-HDL-C, and PL, while interestingly causing no changes to levels of total TAG [13] . Both HL and EL also protect against the generation of small-dense low-density lipoproteins (sdLDL): the plasma of HL/EL-dko mice have sdLDL likely because of impaired PL hydrolysis and increased plasma TAG lipase activity, whereas the plasma from HL-ko and EL-ko mice does not contain sdLDL [13] . However, mouse models of HL and EL deficiency have not clearly defined these lipases as being pro-or anti-atherogenic. Conflicting studies exist that show the absence of HL or EL in mice has either no effect [13] or an improvement [14] on the antiatherogenic process of reverse cholesterol transport. In addition, conflicting studies on plaque formation in the absence of HL or EL exist that are dependent on the genetic background [1] .
Details of the molecular species for each class of lipid in HL and EL deficiency are unknown. Information about the lipidome from models of HL and EL deficiency can be rapidly obtained through mass spectrometry approaches [15] . It is conceivable that the lipidome from models of HL and EL deficiency could contribute to defining how HL and EL may be detrimental or non-influential in atherosclerosis. Information on the lipidome from these models could also provide molecular details about the substrate specificities of HL and EL in vivo.
Materials and Methods

Reagents and Materials
High-performance liquid chromatography (HPLC)-grade methanol and chloroform were purchased from Burdick and Jackson (Morristown, NJ, USA). Arachidic acid (20:0 free fatty acid (FFA)), D10-cis-triheptadecenoin (tri-17:1 TAG), diarachidin (di-20:0 diacylglycerol (DAG)), and cholesteryl heptadecanoate (17:0 cholesteryl ester (CE)) were purchased from Nu-Chek Prep (Elysian, MN, USA). 1,2-Diarachidoyl-sn-glycero-3-phosphocholine (di-20:0 phosphatidylcholine (PtdCho)), 1-heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine (17:0 lysoPtdCho), N-heptadecanoyl-D-erythro-sphingosine (17:0 ceramide (Cer)), and N-heptadecanoyl-D-erythro-sphingosylphosphorylcholine (17:0 sphingomyelin (CerPCho)) were purchased from Avanti Polar Lipids (Alabaster, AL, USA). 4-Nitro-3-(octanoyloxy)benzoic acid (NOB) was purchased from Enzo Life Sciences (Farmingdale, NY, USA). Honey bee venom phospholipase A 2 (PLA 2 ), pentafluorobenzyl bromide, and heparin were purchased from Sigma-Aldrich (St. Louis, MO, USA). HEK293 cells were obtained from ATCC (Manassas, VA, USA). Lipofectamine TM was purchased from Invitrogen (Burlington, ON, Canada). Anti-EL polyclonal antibody (#NB400-111) was purchased from Novus Biologicals (Littleton, CO, USA). Horseradish peroxidase-conjugated anti-rabbit IgG (#SA1-200) was purchased from Pierce Biotechnology (Rockford, IL, USA). ECL TM Prime was purchased from GE Healthcare (Baie d'Ufre, QC, Canada). Animals C57BL/6 (or wild-type (WT)) mice and HL-ko mice on a C57BL/6 background were obtained from Jackson Laboratories-(stock numbers 000664 and 002056, respectively). EL-ko mice [13, 16] and HL/EL-dko mice [13] were previously described. All mice were maintained on a normal chow diet with unlimited access to water and a 12-h light/12-h dark cycle. Plasma was obtained from blood collected from 8-12-week-old female mice that were fasted for 4 h via the retroorbital plexus using heparinized 250 ll Natelson capillary tubes (Fisher Scientific, Pittsburgh, PA) while under anesthesia using isoflurane. Liver samples were collected from mice that were fasted for 4 h following cervical dislocation while under isoflurane anaesthesia. Animals were housed at the University of Pennsylvania, and all studies were approved by the University of Pennsylvania Institutional Animal Care and Use Committee.
Extraction of Plasma and Hepatic Lipids
Lipids from 10 ll plasma or 10 mg liver were extracted using the Bligh-Dyer method [17] , in the presence of internal standards for each lipid assessed. Internal standard lipids added to each plasma sample were 1. 
Mass Spectrometry
For electrospray ionization-mass spectrometry (ESI-MS) analyses, 50 ll of lipid extract was mixed with 200 ll methanol and 2 ll of 10 mM NaOH (in methanol); the mixture was directly injected into a Thermo TSQ Ultra tandem ESI-MS system at a flow rate of 3.5 ll/min. In positive-ion mode, the electrospray needle voltage was 3,500 V with a capillary temperature of 270°C; in negative-ion mode, the electrospray needle voltage was 2,500 V with a capillary temperature of 270°C. Shotgun lipidomic analyses were performed as previously described [15, 18, 19] . Briefly, sodiated adducts of select PtdCho, lysoPtdCho, plasmanylcholines (PakCho), plasmenylcholines (PlsCho), and CerPCho were quantified following their identification in positive-ion mode by scanning for the neutral loss (NL) of choline (m/z 59.1) using a collision energy of -28 eV. ? between m/z 850 and 1,000. (See supplementary Fig. 1c for a representative raw survey scan of the plasma lipids from a WT mouse for TAG). Sodiated adducts of CE were quantified following their identification in positive-ion mode by scanning for the NL of cholestane (m/z 368.5) using a collision energy of -25 eV; all CE data except for 20:5 CE were corrected using our previously described response factors for CE [20] All ESI-MS data were corrected for isotopic contributions, as previously described [15] . FFAs were esterified into pentafluorobenzyl esters and quantified using gas chromatography-mass spectrometry by selective ion monitoring by a similar method to that previously described [21] . For these analyses, we used a DB-1 column (12 m length, 0.2 mm diameter, 0.33 lm film) with He (g) as carrier gas and an Agilent 6890 N gas chromatographer with an Agilent 5973 mass spectrometer equipped with a chemical ion source. Methane was used for chemical ionization. The inlet temperature was 250°C and auxiliary temperature was 280°C. The ion source and quadrupole temperatures were set at 150 and 106°C, respectively. Initial oven conditions were at 150°C for the first 3.5 min, followed by a gradient of 25°C/min to 310°C, followed by 4 min at 310°C. Fatty acids were detected by selective ion monitoring of their negative ion fragments with the loss of the pentafluorobenzyl group. All FFA data were corrected using response factors for FFAs, relative to the internal standard of arachidic acid (supplementary Table 2 Recombinant EL Expression and Phospholipase A 2 Activity HEK293 cells were transiently transfected using Lipofectamine TM with an empty pcDNA3 mammalian expression vector, pcDNA3 containing the cDNA for human EL (GenBank: NM_006033), or with no DNA (mock), exactly as we previously described [22] . Heparinized media from transfected cells were collected at 48 h post-transfection, centrifuged at 1,200 rpm for 10 min to remove cell debris, and aliquots of the supernatant were stored at -80°C, also as we previously described [22] . Proteins in heparinized media samples from transfected cells were denatured and Lipids (2014) 49:505-515 507 separated on 10 % SDS-PAGE gels, then transferred to nitrocellulose membranes. Nitrocellulose membranes were subjected to immunoblot analysis for EL using a 1:500 dilution of the anti-human EL polyclonal antibody. Detection was by chemiluminescence using a 1:1,000 dilution of the horseradish peroxidase-conjugated antirabbit IgG and ECL TM Prime, according to the manufacturer's instructions. To assess sn-2 hydrolytic activity in heparinized media, 100 ll of media was mixed with 100 ll of an assay buffer (150 mM KCl, 10 mM CaCl 2 , 50 mM Tris-HCl, pH 7.5). The mixture was tested for the hydrolysis of NOB to liberate 4-nitro-3-benzoic acid, exactly as previously described [23] . As a positive control, 100 ll of a stock solution with 1,775 U/ml of honey bee venom PLA 2 in phosphate-buffered saline (pH 7.4) was mixed with 100 ll of assay buffer. Assay data were calculated as nmol 4-nitro-3-benzoic acid produced per ml media (or per ml PLA 2 stock) per hour.
Statistical Analyses
Data were analyzed using a one-way analysis of variance (ANOVA) with a 95 % confidence interval, followed by a comparison of groups using a Tukey's test.
Results
We hypothesized that mice with a deficiency in HL and EL will exhibit changes to select molecular species of lipid to account for reported plasma increases in total cholesterol and PL [13] . To test this hypothesis, we quantified molecular species of plasma and hepatic CE and PtdCho levels using ESI-MS; in addition, we quantified select molecular species of TAG, DAG, FFA, lysoPtdCho, CerPCho, Cer, PlsCho, and PakCho.
As previously reported, total cholesterol and PL were significantly elevated in the plasmas of EL-ko and HL/ELdko mice versus WT mice [13] . We observed this for CE in our tandem ESI-MS analyses with the 14:0, 16:0, 18:0, 18:1, 18:2, and 18:3 species of CE ( Fig. 1a and supplementary Table 3 ), as well as the 20:5 species of CE relative to the internal standard (supplementary Fig. 2a ). We also observed significant elevations of select PtdCho species in the plasma of EL-ko and HL/EL-dko mice versus WT mice, notably with the 34:2, 36:1, 36:2, 36:3, 36:4, and 38:4 species ( Fig. 2a and supplementary Table 5 ). The hepatic levels of CE molecular species for HL-ko and HL/ EL-dko mice were comparable to WT levels, but interestingly, the hepatic levels of 14:0, 18:2, 18:0, 20:4, and 22:6 CE were significantly lower in the EL-ko mice versus the WT mice (Fig. 1b and supplementary Table 4 ). The hepatic levels of all of the PtdCho species assessed were not different between groups (Fig. 2b and supplementary  Table 6 ).
LysoPtdCho is a key product of HL and EL hydrolysis of PtdCho. No distinct differences were observed for the plasma levels of lysoPtdCho; amongst the species assessed, only a modest but significant elevation was observed for the 18:0 species of lysoPtdCho in the HL/EL-dko mice versus WT mice ( Fig. 3a and supplementary Table 7) . Similar to what was observed for PtdCho, no differences were observed between all groups for the levels of lysoPtdCho molecular species within the liver ( Fig. 3b and supplementary Table 8 ).
The concentrations of total TAG between WT, HL-ko, EL-ko, and HL/EL-dko mice were previously reported to not be different [13] . However, the dissection of the molecular species of TAG revealed unexpected significant reductions of select species of plasma TAG between lipase Table 9 ). Notably, our data show that the absence of EL in the single knockout and dko mice led to a significant reduction of the 52:4 species of TAG, the absence of HL in the single knockout or dko mice exhibited a significant reduction of the 54:5 species of TAG, and the absence of HL and/or EL led to a significant reduction of the 54:4 species of TAG. No differences were observed for the molecular species of TAG assessed from the livers of all groups of mice ( Fig. 4b and supplementary Table 10 ). Compared to WT mice, mice lacking HL, EL, or both had significantly reduced plasma levels of 16:0-16:0 DAG ( Fig. 5a and supplementary We also uniquely observed that the 18:0-20:4 and 18:0-22:6 species of DAG were significantly elevated, specifically in the plasma of HL/EL-dko mice versus the plasma from WT mice. The hepatic levels of all DAG species assessed in the HL-ko and EL-ko were comparable to the levels observed in WT mice (Fig. 5b and Table 13 ). While the plasma from HL-ko and EL-ko mice exhibited an insignificant reduction of 18:2 and 18:1 FFA species, significantly lower levels were only observed in the plasma from HL/EL-dko mice for these species versus WT mice. Compared to the plasma of WT mice, significantly lower levels of the 20:4 and 22:6 FFA species were observed in the plasma of all lipase-ko mice. With the exception of the 22:6 FFA species in the livers of HL/EL-dko mice, no significant differences were observed between all groups of mice for all species of FFA ( Fig. 6b and supplementary Table 14) .
We assessed two species of CerPCho and six Cer species. We observed a significant increase of 16:0 CerPCho in the plasma of EL-ko and HL/EL-dko mice versus WT, and a significant increase of plasma 18:0 CerPCho in only the HL/EL-dko mice versus WT (Fig. 7a and supplementary Table 15 ). Analyses of livers only showed a modest but significant increase of 16:0 CerPCho levels in HL/ELdko mice versus WT mice (Fig. 7b and supplementary  Table 16 ). On the other hand, no differences were observed Plasma and hepatic levels of diacylglycerol species in lipasedeficient mice. a Plasma lipids were extracted from fasted 8-12-week-old female wild-type (WT, n = 7), hepatic lipase-knockout (HL-ko, n = 5), endothelial lipase-ko (EL-ko, n = 4), and HL/ELdouble ko (DKO, n = 5) mice. The diacylglycerol (DAG) species were semi-quantified as a ratio of intensity relative to the intensity of the internal control diarachidin (di-20:0), as described under ''Materials and Methods''. The average means of data ± SD are shown. b Hepatic lipids were extracted from fasted 8-12-week-old female WT (n = 4), HL-ko (n = 5), EL-ko (n = 4), and DKO (n = 5) mice. The DAG species were semi-quantified as above. The average means of data ± SD are shown. For all statistically significant values, p \ 0.05 for the Cer species assessed in the plasma of all groups of mice ( Fig. 8a and supplementary Table 17) , and a modestly significant increase was observed for only hepatic 16:0 Cer in the HL/EL-dko mice (Fig. 8b and supplementary Table 18 ).
Lastly, we quantified select species of PlsCho and PakCho in the plasma of the lipase-ko mice. Our data interestingly show that compared to the WT mice, the concentrations of the 16:0-18:2, 16:0-18:1, 18:0-18:2, and 18:0-18:1 species of PakCho were significantly increased in the EL-ko and HL/EL-dko mice ( Fig. 9 and supplementary Table 19 ). The increased levels of select PakCho species from the plasma of mice lacking EL suggested that EL might in fact exhibit a PLA 2 activity. To test this possibility, we used heparinized media from HEK293 cells transiently expressing human EL in an enzyme assay using the PLA 2 substrate NOB. From triplicate experiments, we show that EL significantly hydrolyses NOB versus control heparinized media from HEK293 cells transiently transfected with the empty expression vector pcDNA3 (Fig. 10) . Of note, the hydrolysis of NOB by heparinized media from mock transfected cells was comparable to heparinized media from cells transfected with empty vector (supplementary Fig. 3 ). 
Discussion
Our study is the first comprehensive report addressing the lipidome for animal models of HL and EL deficiency, and it provides additional insight into their activities at the molecular level in vivo. Plasma PL concentrations in mice were previously shown to be significantly increased in ELko and HL/EL-dko mice versus WT mice [13] . As expected, we show that this trend exists for most of the species of PtdCho assessed. Our data at the molecular species level clearly reflects the fact that EL exhibits predominantly a phospholipase activity compared to HL [8] . In addition, we show that both HL and EL are complementary in PL metabolism. The observed increases in plasma PtdCho due to the loss of HL and EL in vivo is tied with increases in plasma CE; this is likely because of an increased availability of PtdCho that can be used by lecithin:cholesterol acyltransferase toward esterifying plasma cholesterol. At this point in time, we can only speculate about our interesting finding of the significant reduction of five molecular species of CE in the livers of EL-ko mice. It is possible that EL might have an intracellular function associated with providing select fatty acids for the esterification of cholesterol, but it still remains to be determined if EL is catalytically active within cells. On the other hand, HL is known to become catalytically active early within the secretory pathway of hepatocytes [24, 25] and it appears to play a role in very low-density lipoprotein assembly [26, 27] . Thus, it is also possible that in the absence of EL, intracellular HL might utilize species of fatty acids that are not made available for CE. We also cannot explain our finding that in the absence of EL we observe a significant increase in the plasma concentration of 16:0 CerPCho, and that in the absence of both HL and EL we observe an increase in the plasma concentration of 18:0 CerPCho, plus an increase in hepatic 16:0 CerPCho and 16:0 Cer. Future studies to identify the pool of these species of CerPCho that is/are responsible for the increased plasma concentrations in the absence of HL and EL, plus the identity of the lipoproteins that are responsible for carrying these CerPCho species in the absence of HL and EL, would provide a valuable insight into the connection between HL and EL, and the 16:0 and 18:0 species of CerPCho.
A confusing observation was previously reported for total TAG in mouse plasma, such that concentrations did not change between WT, HL-ko, EL-ko, and HL/EL-dko mice [13] . It would be expected that a deletion of at least HL in mice would lead to raised plasma TAG levels, as human subjects with HL deficiency exhibit hypertriglyceridemia [28] . We did not observe an increase to any of the individual TAG species assessed from plasma, but rather, we unexpectedly observed a decrease in select species in the absence of HL, EL, or both. Both HL and EL appear to have compensatory roles in mouse models that prevent the accumulation of sdLDL in plasma [13] . It is likely that additional compensatory roles exist. EL might compensate for the loss of HL by hydrolysing select species of TAGnotably 52:3, 52:2, 54:5, 54:4, 54:3, 56:7, and 58:8; and HL might compensate for the loss of EL by selectively hydrolysing the 52:4 and 54:4 species of TAG. Lipoprotein lipase (LPL), a family member of HL and EL that exhibits predominantly a TAG lipase activity, was previously shown to be elevated in post-heparin plasma from HL/ELdko mice [13] . Thus, we suspect that an increase of LPL activity would also contribute to the reduction of select species of TAG in plasma.
Two interesting observations were seen through our analyses of DAG: species containing 18:1 or 18:2 acyl chains were typically lower in the plasma of mice with an absence of HL and/or EL, and species containing an 18:0 fatty acyl group together with either 20:4 or 22:6 were significantly elevated specifically in the plasma of HL/ELdko mice. It would be anticipated that plasma DAG levels would be lower in the absence of HL or EL, and that this would be tied to an increase of plasma TAG levels. Since select species of TAG actually decrease, possibly from the influence of a compensating lipase activity, it is likely that the observed reduction of DAG species with 18:1 or 18:2 fatty acyl chains within lipase-ko mouse plasma is in part due also to a compensating lipase activity. More intriguing is the increase in the HL/EL-dko plasma levels of DAG species containing an 18:0 fatty acyl group together with either 20:4 or 22:6. These species of DAG may be derived from the hydrolysis of TAG by LPL, but it is likely that they cannot be processed any further by LPL. In support of this idea, the TAG from plasma intermediate-and lowdensity lipoproteins was previously shown to be enriched with C 20 and C 22 fatty acyl chains in euthyroid and hypothyroid rats, plus the hydrolysis of TAG-rich lipoproteins from rats using heart perfusates containing LPL also led to the accumulation of 20:5 and C 22 fatty acyl chains in intermediate-density lipoproteins [29] . In addition, LPL was shown to exhibit a low efficiency for hydrolysing TAG, DAG, and PtdCho containing 20:4 fatty acyl chains [30] . The levels of 20:4 and 22:6 FFA are interestingly also reduced in mice lacking HL, EL, or both. Thus, our observations indicate that HL and EL can effectively hydrolyse acylglycerides with these fatty acyl groups in vivo. To date, no in vitro studies have been carried out to address the fatty acyl species specificity on the hydrolysis of acylglycerides by EL. However, our observations are in agreement with in vitro data that show HL can effectively hydrolyse DAG containing 20:4 fatty acyl chains [30] .
Our observation of increased plasma concentrations for select PakCho species in the absence of EL, plus the increased plasma concentrations for two species of PlsCho in the absence of both HL and EL, might simply reflect a potentially delayed clearance of lipoprotein-associated ether PLs, since the clearance of plasma HDL is impaired in the absence of both HL and EL [13] . However, because the plasma concentration of the 18:0-20:4 species of PlsCho was not different between groups, we speculated that the raised plasma concentrations of select ether PL species in the absence of EL might be due to a reduced PLA 2 activity that potentially could come from EL. A previous report showed that both sn-1 and sn-2 fatty acids could be liberated from reconstituted HDL particles containing PtdCho by EL, with the rate of the release of sn-1 fatty acids being greater than the rate of fatty acid release from the sn-2 position [31] . The authors of the latter study concluded that the hydrolysis of PtdCho occurs initially at the sn-1 position, followed by a slower release of the fatty acyl chain from the sn-2 position. However, in the same study the authors found that EL could not hydrolyse the 16:0-20:4 species of PlsCho. Consistent with the latter study, we found that in the absence of EL, there was no change versus WT mice to the plasma concentration of the 16:0-20:4 species of PlsCho. Thus, we believe that EL simply cannot hydrolyse this specific PlsCho. Our data show that EL can in fact hydrolyse the artificial PLA 2 substrate NOB. Thus, we suspect it is possible that EL may exhibit an sn-2 hydrolytic activity specifically toward the PlsCho and PakCho species that we identified as being increased in the plasma of mice lacking EL, or both EL and HL. While the use of the aqueous substrate NOB to assess PLA 2 activity eliminates the difficulty of preparing lipid emulsions with reproducible physical properties, the hydrolysis of the NOB ester by EL may not reflect how EL might hydrolyse the sn-2 acyl groups of ether PLs in a lipid environment. Future work to assess the hydrolysis by EL (as well as HL and LPL) of emulsions containing the PlsCho and PakCho species that we identified as being increased in the plasma of mice lacking EL, or both EL and HL, would be necessary to conclusively determine if EL or other sn-1 lipases can in fact exhibit an sn-2 hydrolytic activity toward select molecular species of ether PLs. Such future studies would be important in moving toward the understanding of how EL (and potentially also HL) and the ether PLs we identified could influence atherosclerosis, especially as PLA 2 activity in plasma has a detrimental impact on coronary artery disease [32, 33] .
Overall, our study shows for the first time the influence of HL and EL on individual molecular species of several classes of lipids in vivo using lipidomic methods. Our wealth of data show that there are several differing effects on plasma and hepatic lipids that are unique to HL and EL, but other effects that are also complementary to both HL and EL. Our study also supports the idea that EL might exhibit an sn-2 hydrolytic activity in vivo. Our data provides a reference that could be used to compare the lipidome of human subjects with HL or EL deficiency; any commonly modulated lipids between the two lipidomes would be of great interest for future studies from a lipid standpoint in addressing their possible associations with atherosclerosis.
